Immunogen Inc (DELISTED) (IMGN:DL)
31.23
0.00 (0.00%)
USD |
NASDAQ |
Feb 13, 16:00
Immunogen Cash from Operations (TTM): -197.89M for Sept. 30, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| September 30, 2023 | -197.89M |
| June 30, 2023 | -264.87M |
| March 31, 2023 | -262.12M |
| December 31, 2022 | -229.80M |
| September 30, 2022 | -215.48M |
| June 30, 2022 | -186.31M |
| March 31, 2022 | -166.20M |
| December 31, 2021 | -169.42M |
| September 30, 2021 | -115.01M |
| June 30, 2021 | -110.61M |
| March 31, 2021 | -94.93M |
| December 31, 2020 | -78.62M |
| September 30, 2020 | -119.71M |
| June 30, 2020 | -124.06M |
| March 31, 2020 | -126.88M |
| December 31, 2019 | -88.37M |
| September 30, 2019 | -97.10M |
| June 30, 2019 | -101.95M |
| March 31, 2019 | -106.26M |
| December 31, 2018 | -166.42M |
| September 30, 2018 | -154.55M |
| June 30, 2018 | -68.76M |
| March 31, 2018 | -9.351M |
| December 31, 2017 | 7.645M |
| September 30, 2017 | -10.79M |
| Date | Value |
|---|---|
| June 30, 2017 | -89.63M |
| March 31, 2017 | -139.79M |
| September 30, 2016 | -140.97M |
| June 30, 2016 | -124.48M |
| March 31, 2016 | -120.02M |
| December 31, 2015 | -86.40M |
| September 30, 2015 | -67.74M |
| June 30, 2015 | -55.29M |
| March 31, 2015 | -45.76M |
| December 31, 2014 | -66.40M |
| September 30, 2014 | -48.97M |
| June 30, 2014 | -53.65M |
| March 31, 2014 | -46.34M |
| December 31, 2013 | -39.22M |
| September 30, 2013 | -62.87M |
| June 30, 2013 | -60.30M |
| March 31, 2013 | -64.86M |
| December 31, 2012 | -52.96M |
| September 30, 2012 | -43.73M |
| June 30, 2012 | -34.29M |
| March 31, 2012 | -32.05M |
| December 31, 2011 | -50.42M |
| September 30, 2011 | -4.271M |
| June 30, 2011 | -7.989M |
| March 31, 2011 | -3.774M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-264.87M
Minimum
Jun 2023
-78.62M
Maximum
Dec 2020
-152.74M
Average
-125.48M
Median
Cash from Operations (TTM) Benchmarks
| AbbVie Inc | 22.84B |
| Pfizer Inc | 8.70B |
| Johnson & Johnson | 23.19B |
| Merck & Co Inc | 13.01B |
| Cerevel Therapeutics Holdings Inc | -342.30M |